To distinguish between these two subtypes, immunohistochemical markers, such as diffuse Ber-EP4 and BCL2 staining are typical of basal cell carcinoma, while diffuse CDKN2A and SOX2 expressions are almost exclusively associated with basaloid squamous cell carcinoma. This evidence concerns the gene EPCAM and basal cell carcinoma.